Investor Alert

New York Markets Close in:

May 27, 2022, 5:05 p.m. EDT

Top Penny Stocks to Buy Now? 3 to Watch in June 2022

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Regulus Therapeutics Inc. (RGLS)
  • X
    Ontrak Inc. (OTRK)
  • X
    Tenon Medical Inc. (TNON)

or Cancel Already have a watchlist? Log In

May 27, 2022 (Penny Stocks via COMTEX) -- 3 Penny Stocks to Watch in June 2022

With the stock market up today, those investing in penny stocks are excited for what the future may bring. Now, with penny stocks, it is crucial to remember that risk will always be inherently high. This is due to the fact that penny stocks are under $5 per share, and therefore they are likely to move in price substantially.

However, for those who are willing to take on the risk, penny stocks can offer a high return on investment. So, if you're thinking about investing in penny stocks, be sure to do your research first and always remember to tread carefully. In addition, investors need to have a well-thought-out trading strategy in place in order to be successful with penny stocks. While there is some bullish sentiment in the stock market right now, it's important to remember that things can always change quickly.

[Read More] Hot Penny Stocks to Watch as May Ends

So, be sure to stay up-to-date on the latest news and information in order to make the best possible decisions for your investments. Also, make sure to consider whether you're more interested in investing in the short or long term. Penny stocks can be a great way to make money in the short term, but they may also be more volatile.

If you're looking to invest for the long term, you may want to consider stocks that are a bit more stable. Ultimately, it's important to find stocks that fit your own personal investing style and risk tolerance. So, with this in mind, here are three penny stocks that could be worth watching.

3 Penny Stocks to Add to Your June 2022 Watchlist

  1. Regulus Therapeutics Inc. ( NASDAQ: RGLS )

  2. Ontrak Inc. ( NASDAQ: OTRK )

  3. Tenon Medical Inc. ( NASDAQ: TNON )

Regulus Therapeutics Inc. /zigman2/quotes/202916513/composite RGLS -3.42%

One of the bigger gainers of the day on May 27th is RGLS stock. At EOD, shares of RGLS managed to shoot up by over 12.5%. And in the past five days shares of RGLS have climbed by over 24% and more than 47% in the past month.

During that time, we've covered RGLS on numerous occasions. To understand why shares of RGLS stock are moving, we have to take a closer look at the company. The most recent update from Regulus came on May 12th when it reported its Q1 2022 financial results as well as some updates. In the results, it announced the FDA acceptance of its IND application for RGLS8429.

Right now, we continue to see a sizable amount of bullish attention on biotech stocks as a whole. And because of that, RGLS could be worth adding to your list of penny stocks to watch.

Ontrak Inc. /zigman2/quotes/200309057/composite OTRK +3.66%

During trading on May 27th, shares of OTRK stock managed to shoot up by over 20.6%. This sizable gain gives it a one month uptick of more than 50%, which is no small feat. While we do see large gains like this with penny stocks, it is crucial to understand why it occurred.

[Read More] Top Penny Stocks Today: What's Moving AVDL, BKSY, NILE, INO, & ALLR

For that reason, we have to take a closer look at the company and any recent announcements from it. While it is tough to say why shares are climbing right now, the company did release its 2022 financial results from its first quarter a few weeks ago. In the report, it announced revenue of $5.3 million as well as the execution of a note purchase agreement with Acuity's Capital for $25 million in borrowings.

US : U.S.: Nasdaq
$ 1.41
-0.05 -3.42%
Volume: 19,210
Dec. 9, 2022 1:37p
P/E Ratio
Dividend Yield
Market Cap
$24.59 million
Rev. per Employee
US : U.S.: Nasdaq
$ 0.38
+0.01 +3.66%
Volume: 105,166
Dec. 9, 2022 1:36p
P/E Ratio
Dividend Yield
Market Cap
$9.82 million
Rev. per Employee
1 2
This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.